Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 7
1946 11
1947 17
1948 17
1949 26
1950 28
1951 40
1952 34
1953 27
1954 24
1955 40
1956 33
1957 43
1958 44
1959 52
1960 50
1961 53
1962 54
1963 65
1964 98
1965 71
1966 76
1967 83
1968 72
1969 90
1970 84
1971 96
1972 105
1973 109
1974 108
1975 75
1976 64
1977 76
1978 72
1979 76
1980 85
1981 67
1982 80
1983 94
1984 92
1985 145
1986 269
1987 314
1988 316
1989 376
1990 413
1991 411
1992 499
1993 461
1994 445
1995 456
1996 457
1997 441
1998 469
1999 463
2000 496
2001 495
2002 613
2003 553
2004 557
2005 581
2006 635
2007 696
2008 719
2009 773
2010 869
2011 967
2012 1104
2013 1002
2014 1006
2015 1011
2016 1013
2017 1118
2018 1053
2019 1032
2020 1051
2021 1182
2022 1079
2023 1050
2024 456

Text availability

Article attribute

Article type

Publication date

Search Results

26,872 results

Results by year

Filters applied: . Clear all
Page 1
Myelodysplastic Syndromes.
Cazzola M. Cazzola M. N Engl J Med. 2020 Oct 1;383(14):1358-1374. doi: 10.1056/NEJMra1904794. N Engl J Med. 2020. PMID: 32997910 Review. No abstract available.
The International Consensus Classification of myelodysplastic syndromes and related entities.
Hasserjian RP, Orazi A, Orfao A, Rozman M, Wang SA. Hasserjian RP, et al. Virchows Arch. 2023 Jan;482(1):39-51. doi: 10.1007/s00428-022-03417-1. Virchows Arch. 2023. PMID: 36287260 Review.
The International Consensus Classification (ICC) of myeloid neoplasms and acute leukemia has updated the classification of myelodysplastic syndromes (MDSs) and placed MDS in a broader group of clonal cytopenias that includes clonal cytopenia of undetermined signific …
The International Consensus Classification (ICC) of myeloid neoplasms and acute leukemia has updated the classification of myelodysplasti
Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update.
Jain AG, Zhang L, Bennett JM, Komrokji R. Jain AG, et al. Ann Lab Med. 2022 May 1;42(3):299-305. doi: 10.3343/alm.2022.42.3.299. Ann Lab Med. 2022. PMID: 34907099 Free PMC article. Review.
Myelodysplastic syndrome (MDS) is a diverse hematological malignancy with a wide spectrum of presentations and implications. ...
Myelodysplastic syndrome (MDS) is a diverse hematological malignancy with a wide spectrum of presentations and implications. ...
Myelodysplastic syndromes.
[No authors listed] [No authors listed] Nat Rev Dis Primers. 2022 Nov 17;8(1):73. doi: 10.1038/s41572-022-00407-0. Nat Rev Dis Primers. 2022. PMID: 36396663 No abstract available.
The Genetics of Myelodysplastic Syndromes: Clinical Relevance.
Chiereghin C, Travaglino E, Zampini M, Saba E, Saitta C, Riva E, Bersanelli M, Della Porta MG. Chiereghin C, et al. Genes (Basel). 2021 Jul 27;12(8):1144. doi: 10.3390/genes12081144. Genes (Basel). 2021. PMID: 34440317 Free PMC article. Review.
Myelodysplastic syndromes (MDS) are a clonal disease arising from hematopoietic stem cells, that are characterized by ineffective hematopoiesis (leading to peripheral blood cytopenia) and by an increased risk of evolution into acute myeloid leukemia. ...In this arti
Myelodysplastic syndromes (MDS) are a clonal disease arising from hematopoietic stem cells, that are characterized by ineffect
Myelodysplastic syndromes.
Zhou J, Orazi A, Czader MB. Zhou J, et al. Semin Diagn Pathol. 2011 Nov;28(4):258-72. doi: 10.1053/j.semdp.2011.08.005. Semin Diagn Pathol. 2011. PMID: 22195404 Review.
Myelodysplastic syndromes (MDS) are hematopoietic neoplasms characterized by an ineffective hematopoiesis associated with cytopenia(s), functional abnormalities of bone marrow lineages, morphologic dysplasia, and a progression to acute myeloid leukemia. ...
Myelodysplastic syndromes (MDS) are hematopoietic neoplasms characterized by an ineffective hematopoiesis associated with cyto
Myelodysplastic syndromes.
Scott BL, Deeg HJ. Scott BL, et al. Annu Rev Med. 2010;61:345-58. doi: 10.1146/annurev.med.051308.132852. Annu Rev Med. 2010. PMID: 20059342 Review.
Myelodysplastic syndromes (MDS) represent a collection of stem cell disorders characterized by impaired hematopoiesis resulting in low peripheral blood counts. ...
Myelodysplastic syndromes (MDS) represent a collection of stem cell disorders characterized by impaired hematopoiesis resultin
Myelodysplastic syndromes in children.
Galaverna F, Ruggeri A, Locatelli F. Galaverna F, et al. Curr Opin Oncol. 2018 Nov;30(6):402-408. doi: 10.1097/CCO.0000000000000488. Curr Opin Oncol. 2018. PMID: 30222640 Review.
PURPOSE OF REVIEW: Myelodysplastic syndromes (MDSs) are rare disorders in children, showing peculiar clinical manifestations and biological features. ...Moreover, germline syndromes predisposing to develop MDS/acute myeloid leukemia have been recently identif …
PURPOSE OF REVIEW: Myelodysplastic syndromes (MDSs) are rare disorders in children, showing peculiar clinical manifestations a …
Myelodysplastic syndromes.
Tefferi A, Vardiman JW. Tefferi A, et al. N Engl J Med. 2009 Nov 5;361(19):1872-85. doi: 10.1056/NEJMra0902908. N Engl J Med. 2009. PMID: 19890130 Review. No abstract available.
Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it.
Zeidan AM, Shallis RM, Wang R, Davidoff A, Ma X. Zeidan AM, et al. Blood Rev. 2019 Mar;34:1-15. doi: 10.1016/j.blre.2018.09.001. Epub 2018 Sep 21. Blood Rev. 2019. PMID: 30314642 Review.
Myelodysplastic syndromes (MDS) consist of a heterogeneous group of myeloid neoplasms characterized by inefficient hematopoiesis, variable cytopenias and a considerable risk of progression to acute myeloid leukemia. ...
Myelodysplastic syndromes (MDS) consist of a heterogeneous group of myeloid neoplasms characterized by inefficient hematopoies
26,872 results
You have reached the last available page of results. Please see the User Guide for more information.